Showing results (2111-2120 of 2,922) with videos related to
Sort By:
Pageof 293
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 2006
The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritisX Cai, Y F Wong, H Zhou, et al.Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|April 24, 2025
[Endoscopic submucosal dissection of gastrointestinal polyps with a novel plasma radio frequency generator and a disposable mucosal incision knife: A prospective, multicenter, non-inferiority, randomized, controlled clinical trial]B H Song, G J Shi, X Y Xu, et al.Genetics and Molecular Research : GMR|February 25, 2016
Haplotypes of qGL3 and their roles in grain size regulation with GS3 alleles in riceY D Zhang, Z Zhu, Q Y Zhao, et al.Genetics and Molecular Research : GMR|May 14, 2016
Analysis of QTLs for panicle exsertion and its relationship with yield and yield-related traits in rice (Oryza sativa L.)C F Zhao, T Chen, Q Y Zhao, et al.British Journal of Pharmacology|June 22, 2016
Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chlorideL P Li, F F Song, Y Y Weng, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|February 20, 2020
[Comparison of radiological and clinicopathological features of craniofacial fibro-osseous lesions]X D Yang, G Xu, L H Song, et al.Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|February 20, 2020
[A novel and simplified closure method for defect closure after endoscopic full-thickness resection of gastric submucosal tumors: short-term outcomes of "Shao-Mai" closure method]J He, B S Chen, P H Zhou, et al.Diabetologia|August 14, 2012
Erythrocyte trans-fatty acids, type 2 diabetes and cardiovascular risk factors in middle-aged and older Chinese individualsD X Yu, Q Sun, X W Ye, et al.Epidemiology and Infection|July 17, 2012
Population-based estimate of the burden of acute gastrointestinal illness in Jiangsu province, China, 2010-2011Y J Zhou, Y Dai, B J Yuan, et al.Drug Safety|July 31, 2024
Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA LabelingGeorge A Neyarapally, Leihong Wu, Joshua Xu, et al.Pageof 293